Percutaneous exposure to the nerve agent VX: Efficacy of combined atropine, obidoxime and diazepam treatment
Authors:
- Marloes J.A. JoosenMJMarloes J.A. Joosen
- Marcel J. van der SchansMSMarcel J. van der Schans
- Herman P.M. van HeldenHHHerman P.M. van Helden
- 1 October 2010
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 188 (1) , 255-263
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Galantamine is a novel post-exposure therapeutic against lethal VX challengeToxicology and Applied Pharmacology, 2009
- Toxicodynamic analysis of the combined cholinesterase inhibition by paraoxon and methamidophos in human whole bloodToxicology and Applied Pharmacology, 2009
- A paired comparison between human skin and hairless guinea pig skinin vitropermeability and lag time measurements for 6 industrial chemicalsCutaneous and Ocular Toxicology, 2009
- Percutaneous Exposure to VX: Clinical Signs, Effects on Brain Acetylcholine Levels and EEGNeurochemical Research, 2007
- Development of next generation medical countermeasures to nerve agent poisoningToxicology, 2007
- Anticonvulsants for Nerve Agent-Induced Seizures: The Influence of the Therapeutic Dose of AtropineThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitroToxicology in Vitro, 2006
- Clinical Aspects of Percutaneous Poisoning by the Chemical Warfare Agent VX: Effects of Application Site and DecontaminationMilitary Medicine, 2004
- Toxicokinetics of the nerve agent (±)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administrationToxicology and Applied Pharmacology, 2003
- Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphatesArchives of Toxicology, 2002